About Joost Bakker

This author has not yet written his bio.
Meanwhile let's just say that we are proud Joost Bakker contributed with 50 entries.

Entries by Joost Bakker

ISA Pharmaceuticals Initiates Phase I/II Clinical Trial of ISA101 in Patients with Anal Intraepithelial Neoplasia (AIN)

Publication Demonstrates Superior Activity of ISA Pharmaceuticals´ SLP® Vaccines Compared to Whole Protein Vaccines

Three Peer-Reviewed Papers by ISA Pharmaceuticals Introduce Strategies to Improve Immunotherapy Against Cancer

ISA Pharmaceuticals Strengthens Management Team

Novel AMPLIVANT™ Technology Introduced at AACR Annual Meeting 2013

Prof. Cornelis Melief to Present Novel AMPLIVANT™ Platform at AACR Annual Meeting 2013

ISA Pharmaceuticals Secures EUR 8 Million Funding

ISA Pharmaceuticals strengthens its Supervisory Board with the appointment of Professor Jan van de Winkel

FDA grants ISA Pharmaceuticals Orphan Drug Designation for the treatment of Vulvar Intraepithelial Neoplasia with its lead product ISA-HPV-SLP®

ISA Pharmaceuticals closes a License Agreement with Transgene aimed at the development of novel vaccines for TB